RxDoctor Payments Data

Christopher Seuferling, DPM

Podiatrist · Portland, ORNPI 1366596348

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.9% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Smith+Nephew at 35.8% of the total. That places this record below the midpoint for podiatrist clinicians in OR, where the typical reported total is $1,169.

$1,587in general payments, 2019–2025

Across 82 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$568
  • IBSA Pharma Inc.$299
  • Integra Lifesciences Corporation$190
  • Nevro Corp.$84
  • DJO, LLC$62
  • Mimedx Group, Inc.$54
  • plus $330 from 13 others

What the payments were for

  • Food & beverage$1,44291%
  • Other$1459%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,587 in reported general payments places this provider in the 50th percentile of 74 podiatrist providers in Oregon.

See all podiatrist providers in Oregon

Medicare billing

Part B allowed, 2024
$136,884
Medicare patients
213
Services billed
1,714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin48$1,787
Betamethasone Dipropionate37$1,657
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip48$1,188
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav57$749
Gabapentin44$447
Terbinafine Hcl24$402
Ketoconazole14$304
Doxycycline Hyclate28$248
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$246
Oxycodone Hcl19$184
Cephalexin16$177
Lidocaine-PrilocaineLidocaine/Prilocaine11$173
Clotrimazole12$134
Tramadol Hcl30$133

Paid to pharmacies, not to this prescriber.

Other podiatrist in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →